Targets such as HIF-1α may play competing roles in GvHD, with HIF-1α potentially promoting GvHD by enhancing glycolysis (a key pathway for alloreactive immune cells), but it may also prevent tissue damage in the hypoxic microenvironment associated with GvHD. This evidence concerns the gene HIF1A and graft versus host disease.